Good MorningEquity markets rebounded on Wednesday, but the move may be short-lived. Data due today may reinforce the idea of hot inflation and Fed hawkishness, pushing the timeline for rate cuts out another few months. Among the causes for concern is a spike in mortgage rates, with home buyers pulling back. Another is a risk to the banking sector due to higher for longer interest rates. The risk to small and regional banks is growing by the day, and some may not last until the FOMC decides lower rates are acceptable.
Among the data points due out today is Retail Sales. Retail Sales are expected to fall compared to last year but may outpace consensus due to higher prices at the register and lingering consumer resilience at home. On the one hand, a decline in retail sales may indicate the start of a larger economic slowdown, while on the other hand, a hot read will keep the Fed policy tight. In both cases risk for equities abounds. Featured: This Stock Could Go Up 66% or More. (Chaikin Analytics) 
|
Stocks | | |
The oil refiners' exchange-traded fund (ETF), the VanEck Oil Refiners ETF (NYSEARCA: CRAK), is outperforming the broader Energy Select Sector SPDR Fund (NYSEARCA: XLE) on a one-month, three-month and one-year basis.
The top components in the CRAK ETF are Marathon Petrole... Read the Full Story |
|
From Our PartnersAre you ready to invest in a brighter, greener future? Look no further – the #1 Alternative Energy Stock is here, leading the charge towards sustainable and profitable solutions!
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | | | Download your complimentary copy now! |
|
Markets | | |
There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a quarterly basis. However, it takes capital to buy and hold the underlying shares. If you already own stoc... Read the Full Story |
|
Stocks | | |
2024 is shaping up to be a pivotal year for the biotechnology industry.
In recent years, emergency Covid vaccines have ushered in several groundbreaking innovations that have changed the way drugs are developed and health care is administered. Advancements in the treatment of cancer, Alzheimer&rs... Read the Full Story |
|
From Our PartnersImagine focusing on only the best stock in the world…
And only trading it just a handful of times per year…
And absolutely crushing the performance of pretty much every top hedge fund out there.
That’s the idea behind this new trade setup. | | | | Tap Here to See How it Works |
|
Markets | | |
The Kraft Heinz Company (NASDAQ: KHC) Q4 report is not the stuff of legend but reveals several details income investors should heed. Among them are improving margins, favorable guidance, and cash flow, which suggests an inflection point is at hand for this consumer staple. The takeaway is that Kra... Read the Full Story |
|
Markets | | | Japan’s economy is now the world’s fourth-largest after it contracted in the last quarter of 2023 and fell behind Germany. The government reported the economy shrank at an annual rate of 0.4% in October to December, according to Cabinet Office data on real GDP released Thursday, though it grew 1.9% ... Read the Full Story |
|
From Our PartnersIn the past year, AI has amazed us all with its achievements. It can predict weather, recommend winning stocks, create original art, write computer code, detect skin cancer – and, shockingly, it can do all these things better than most humans. But when you see its latest leap (revealed in on-location footage), you may want to pinch yourself! | | | | Get the full scoop here |
|
Markets | | |
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the medical sector occurred on December 8, 2023, when the U.S. FDA approved Casgevy, the first FDA... Read the Full Story |
|
Markets | | | The British economy fell into recession at the end of 2023 for the first time since the onset of the coronavirus pandemic, as output shrank more than anticipated in the final three months of the year, official figures showed Thursday.In what is a blow for the governing Conservative Party ahead of a ... Read the Full Story |
|
Markets | | | Lyft shares jumped 62% after the bell Tuesday thanks in part to a typo in the ride-hailing company’s earnings release that sent investors’ auto-trading algorithms — also known as “bots” — into a buying frenzy Read the Full Story |
|
Markets | | | How much spending power do U.S. shoppers have left?That's the key question as big U.S. retailers get set to report their latest quarterly results. Even when inflation was high, interest rates were shooting upward and worries were rising that a recession seemed inevitable, U.S. consumers kept spendin... Read the Full Story |
|
Markets | | | Jayson Tatum remembers how it felt when he first bought a home. “It didn’t seem real,” said the Boston Celtics power forward, a five-time NBA All-Star set to start for the Eastern Conference in this year's All-Star Game on Sunday. Tatum told The Associated Press in an interview how he wants to help ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. | | View Today's Stock Pick |
|
